Fortress Biotech, formerly known as Coronado Biosciences, was founded by Lindsay Rosenwald in 2016. It is headquartered in New York, United States. It is a biotechnology company that specializes in gene therapy, pain management, and central nervous system(CNS) disorders.
Timeline
July 2011
Fortress Biotech raises a $25,800,000 series C round from National Securities Corporation.
2011
Fortress Biotech was founded by Lindsay Rosenwald.
January 2011
Fortress Biotech raises a $14,100,000 venture round.
July 16, 2010
Fortress Biotech raises a $3,900,000 series C round.
August 2009
Fortress Biotech raises a $1,200,000 convertible note.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
May 10, 2021
BioSpace
Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop Dotinurad in North America and Europe - read this article along with other careers information, tips and advice on BioSpace
The Schall Law Firm
January 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fortress Biotech,...
Pomerantz LLP
January 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc. ("Fortress" or the "Company") (NASDAQ: FBIO)...
The Schall Law Firm
December 30, 2020
www.prnewswire.com:443
/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fortress Biotech,...
Law Offices of Howard G. Smith
December 18, 2020
www.prnewswire.com:443
/PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming January 26, 2021 deadline to file a lead plaintiff motion in the case filed on...
SHOW MORE
References
6
Type: Web page
https://sec.report/CIK/00014292607
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1429260&owner=exclude